LFMD News

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

Form 8-K

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LifeMD to Participate in Two Investor Conferences During March

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Jasper Therapeutics, Inc. (JSPR), KBR, Inc. (KBR), LifeMD, Inc. (LFMD), and Lineage, Inc. (LINE)

Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock